Global Cellular Health Screening Market | Growth, Trends, and Forecast (2017-2022)
Factors such as the increasing adoption of telomere performance programs for leading a healthy life; growing importance of healthy life expectancy (HALE); rising government focus towards preventive healthcare; rising geriatric population and resultant growth in the need for cellular health screening; increasing research activities; growing adoption of the direct-to-consumer approach; and the increasing burden of chronic diseases are expected to drive the growth of this market. On the other hand, problems associated with the transport of samples and differences in the cost of test kits offered by different companies are expected to restrain the growth of this market during the forecast period. The global Cellular Health Screening Market is expected to reach USD 3.42 billion by 2022 from USD 2.12 billion in 2017, at a CAGR of 10.0% during the forecast period. Major Market Developments: In 2016, Telomere Diagnostics launched TeloYears, its new telomere test. In 2015, SpectraCel...